- TBPH -1.00%
Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years
Yahoo Finance · 3 weeks ago
Search results
- 9.89Add to watchlist-0.10 (-1.00%)At close: Wed. Jul 17, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Pre-Market Time
- Open9.90High10.04Low9.84
- Mkt Cap480.98MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close9.9952 Wk. Low8.1352 Wk. High11.71
Top storiesRelated stocks
6 days ago · See the latest Theravance Biopharma Inc stock price (TBPH:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
View Theravance Biopharma Inc TBPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
6 days ago · Get a real-time Theravance Biopharma, Inc. (TBPH) stock price quote with breaking news, financials, statistics, charts and more.
- www.marketwatch.com
- › …
- › Quotes
- › Stocks
- › United States
Jun 21, 2024 · TBPH | Complete Theravance Biopharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
View the latest Theravance Biopharma Inc. (TBPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Get the latest Theravance Biopharma, Inc. (TBPH) stock news and headlines to help you in your trading and investing decisions.
Stock analysis for Theravance Biopharma Inc (TBPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Theravance Biopharma, Inc. Ordinary Shares (TBPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin.
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily,...
